搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
17 小时
on MSN
Viking Therapeutics, Inc. (VKTX): Biotech Breakthrough or Short Sellers’ Target?
We recently published a list of 10 Worst Booming Stocks to Buy According to Short Sellers. In this article, we are going to ...
18 小时
Prediction: This Is What Eli Lilly Stock Will Do Next (Hint: It's Not a Stock Split)
With a market capitalization of over $800 billion, Eli Lilly (NYSE: LLY) is the largest pharmaceutical company in the world.
purewow
1 天
What Are Ozempic Burps? A Doctor Explains Everything You Need to Know About the Weird but ...
So what are Ozempic burps, exactly? Read on for the full scoop from a medical expert , plus some sage advice on how best to ...
The American Journal of Managed Care
1 天
5 Things Americans Should Know About Weight Loss Drugs
Weight loss drugs have gained attention as a tool to help combat obesity, but understanding how they work, who they’re for, ...
1 天
NVO Stock Loses Around $29B in 3 Months: Buy the Dip or Steer Clear?
Despite the current downward trend of Novo Nordisk, it is an excellent stock to buy for long-term gains, driven by the ...
1 天
The Prototype: The Scientist Betting That Worm Secretions Fix Autoimmune Diseases
Plus: The story behind the award-winning science that led to Ozempic, the next astronaut launch and why homework is good for ...
ConsumerAffairs
2 天
Zepbound vs. Ozempic: Which is best for weight loss?
For significant weight loss, Zepbound may be the better option. If you have Type 2 diabetes and are looking for a dual ...
2 天
A Guide to Type 2 Diabetes: Symptoms, Causes and Treatments
Type 2 diabetes is characterized by the body's inability to use insulin effectively. Insulin is a hormone that helps regulate metabolism properly. The condition is the most common type of ...
2 天
Novo Nordisk: The Street Is Not Seeing The Growth Acceleration Potential
Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...
Zawya
3 天
Obesity drug developer BioAge seeks up to $587mln valuation in US IPO
Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...
ophthalmologyadvisor
3 天
GLP-1R Agonists Treatments May Slightly Decrease Intraocular Pressure
GLP-1R agonist use is associated with a decrease in IOP, although this correlation is not statistically significant.
3 天
NC’s Folwell, Sen. Bernie Sanders scrutinize costs of blockbuster weight-loss drugs
In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈